Drug-labels.com

J07B Viral vaccines

ATC class of level 3 – pharmacological subgroup

This page lists the patient medication information or the product monograph for 78 drugs in this drug class and its subclasses.

Place in the ATC system

  1. J Antiinfectives for systemic use 1,101 drugs
    1. J07 Vaccines 119 drugs
      1. J07B Viral vaccines 78 drugs
        1. J07BA Encephalitis vaccines 2 drugs
        2. J07BB Influenza vaccines 25 drugs
        3. J07BC Hepatitis vaccines 11 drugs
        4. J07BD Measles vaccines 4 drugs
        5. J07BF Poliomyelitis vaccines 1 drug
        6. J07BG Rabies vaccines 2 drugs
        7. J07BH Rota virus diarrhea vaccines 2 drugs
        8. J07BK Varicella zoster vaccines 2 drugs
        9. J07BL Yellow fever vaccines 1 drug
        10. J07BM Papillomavirus vaccines 3 drugs
        11. J07BX Other viral vaccines 6 drugs

Active ingredients of the class

Drugs in the class and its subclasses

DrugRx or OTC
Abrysvo PM (J07BX05 Respiratory syncytial virus vaccine) –
ACAM2000 PM (J07BX01 Smallpox and mpox vaccines) –
Afluria Tetra PM (J07BB02 Influenza, inactivated, split virus or surface antigen) –
Agriflu PM (J07BB02 Influenza, inactivated, split virus or surface antigen) –
Arepanrix H5N1 PM (J07BB02 Influenza, inactivated, split virus or surface antigen) –
Arexvy PM (J07BX05 Respiratory syncytial virus vaccine) –
Avaxim PM (J07BC02 Hepatitis A, inactivated, whole virus) –
Avaxim - Pediatric (J07BC02 Hepatitis A, inactivated, whole virus) –
Avaxim - Pediatric -(5mL Vial) PM (J07BC02 Hepatitis A, inactivated, whole virus) –
Cervarix (J07BM02 Papillomavirus (human types 16,18)) –
Comirnaty (Biontech Manufacturing, PM 00069992) PM (J07BN01 COVID-19, rna-based vaccine) –
Comirnaty (Biontech Manufacturing, PM 00086127) PM (J07BN01 COVID-19, rna-based vaccine) –
Comirnaty Omicron Xbb.1.5 PM (J07BN01 COVID-19, rna-based vaccine) prescription (Rx)
Comirnaty Original & Omicron Ba.4/Ba.5 PM (J07BN01 COVID-19, rna-based vaccine) –
Comirnaty Original/Omicron Ba.1 PM (J07BN01 COVID-19, rna-based vaccine) –
Covifenz PM (J07BN04 COVID-19, protein subunit) –
Covishield PM (J07BN02 COVID-19, viral vector, non-replicating) –
Engerix-B (Glaxosmithkline, 10 mcg, 20 mcg) PM (J07BC01 Hepatitis B, purified antigen) –
Engerix-B (Glaxosmithkline, 20 mcg, 10 mcg) PM (J07BC01 Hepatitis B, purified antigen) –
Ervebo (J07BX02 Ebola vaccines) –
Fluad (J07BB02 Influenza, inactivated, split virus or surface antigen) –
Flucelvax PM (J07BB02 Influenza, inactivated, split virus or surface antigen) –
Flucelvax Quad PM (J07BB02 Influenza, inactivated, split virus or surface antigen) –
Flulaval Tetra PM (J07BB02 Influenza, inactivated, split virus or surface antigen) –
Flumist PM (J07BB03 Influenza, live attenuated) –
Flumist Quadrivalent PM (J07BB03 Influenza, live attenuated) –
Fluviral (Id Biomedical Corporation of Quebec, PM 00053162) PM (J07BB01 Influenza, inactivated, whole virus) –
Fluviral (Id Biomedical Corporation of Quebec, PM 00085961) PM (J07BB02 Influenza, inactivated, split virus or surface antigen) –
Fluzone (Sanofi Pasteur) PM (J07BB02 Influenza, inactivated, split virus or surface antigen) –
Fluzone (Sanofi Vaccines Canada) PM (J07BB02 Influenza, inactivated, split virus or surface antigen) –
Fluzone High-Dose (J07BB02 Influenza, inactivated, split virus or surface antigen) –
Fluzone High-Dose Quadrivalent PM (J07BB02 Influenza, inactivated, split virus or surface antigen) –
Fluzone Quadrivalent (Sanofi Vaccines Canada, 15 mcg / 15 mcg / 15 mcg / 15 mcg, 30 mcg / 30 mcg / 30 mcg / 30 mcg) PM (J07BB02 Influenza, inactivated, split virus or surface antigen) –
Fluzone Quadrivalent (Sanofi Vaccines Canada, 7.5 mcg / 7.5 mcg / 7.5 mcg / 7.5 mcg, 15 mcg / 15 mcg / 15 mcg / 15 mcg) PM (J07BB02 Influenza, inactivated, split virus or surface antigen) –
Foclivia PM (J07BB02 Influenza, inactivated, split virus or surface antigen) –
Fsme-Immun (J07BA01 Encephalitis, tick borne, inactivated, whole virus) –
Gardasil PM (J07BM01 Papillomavirus (human types 6,11,16,18)) –
Gardasil 9 PM (J07BM03 Papillomavirus (human types 6,11,16,18,31,33,45,52,58)) –
Havrix 1440 (J07BC02 Hepatitis A, inactivated, whole virus) –
Imovax Polio PM (J07BF03 Poliomyelitis, trivalent, inactivated, whole virus) –
Imovax Rabies PM (J07BG01 Rabies, inactivated, whole virus) –
Imvamune (J07BX01 Smallpox and mpox vaccines) –
Influenza A (H1N1) 2009 Pandemic Monovalent Vaccine (Without Adjuvant) PM (J07BB02 Influenza, inactivated, split virus or surface antigen) –
Influvac PM (J07BB01 Influenza, inactivated, whole virus) –
Influvac Tetra (J07BB02 Influenza, inactivated, split virus or surface antigen) –
Intanza PM (J07BB02 Influenza, inactivated, split virus or surface antigen) –
Ixchiq PM (J07BP01 Chikungunya, live attenuated) –
Ixiaro PM (J07BA02 Encephalitis, japanese, inactivated, whole virus) –
Jcovden (J07BN02 COVID-19, viral vector, non-replicating) –
M-M-R II PM (J07BD52 Measles, combin. with mumps and rubella, live attenuated) –
Mnexspike PM (J07BN01 COVID-19, rna-based vaccine) –
Mresvia PM (J07BX05 Respiratory syncytial virus vaccine) –
Nuvaxovid (Novavax) PM (J07BN04 COVID-19, protein subunit) –
Nuvaxovid (Sanofi Vaccines Canada) PM (J07BN04 COVID-19, protein subunit) –
Panenza PM (J07BB02 Influenza, inactivated, split virus or surface antigen) –
Prehevbrio PM (J07BC01 Hepatitis B, purified antigen) –
Priorix PM (J07BD52 Measles, combin. with mumps and rubella, live attenuated) –
Priorix-Tetra (J07BD54 Measles, combinations with mumps, rubella and varicella, live attenuated) –
Proquad (J07BD54 Measles, combinations with mumps, rubella and varicella, live attenuated) –
Rabavert PM (J07BG01 Rabies, inactivated, whole virus) –
Recombivax Hb PM (J07BC01 Hepatitis B, purified antigen) –
Recombivax Hb (with Preservative) PM (J07BC01 Hepatitis B, purified antigen) –
Rotarix PM (J07BH01 Rota virus, live attenuated) –
Rotateq PM (J07BH02 Rota virus, pentavalent, live, reassorted) –
Spikevax (Moderna Biopharma Canada, 0.1 mg, 50 mcg, 25 mcg) PM (J07BN01 COVID-19, rna-based vaccine) –
Spikevax (Moderna Biopharma Canada, 0.2 mg, 0.1 mg) PM (J07BN01 COVID-19, rna-based vaccine) –
Spikevax Bivalent PM (J07BN01 COVID-19, rna-based vaccine) –
Spikevax Bivalent (Original / Omicron Ba.4/5) PM (J07BN01 COVID-19, rna-based vaccine) –
Supemtek (J07BB02 Influenza, inactivated, split virus or surface antigen) –
Twinrix PM (J07BC20 Combinations) –
Vaqta PM (J07BC02 Hepatitis A, inactivated, whole virus) –
Varilrix PM (J07BK01 Varicella, live attenuated) –
Varivax III PM (J07BK01 Varicella, live attenuated) –
Vaxigrip PM (J07BB02 Influenza, inactivated, split virus or surface antigen) –
Vaxzevria (Astrazeneca Canada, PM 00062879) (J07BN02 COVID-19, viral vector, non-replicating) –
Vaxzevria (Astrazeneca Canada, PM 00068758) (J07BN02 COVID-19, viral vector, non-replicating) –
Vimkunya PM (J07BP02 Chikungunya, virus-like particles) prescription (Rx)
Yf-Vax PM (J07BL01 Yellow fever, live attenuated) –

Other classes of the same level

Other names of the drug class

Sources

  • Patient medication information and product monographs: Health Canada, Drug Product Database
  • Active ingredients, ATC codes and Rx or OTC status: Health Canada, Drug Product Database
  • World Health Organization (WHO): ATC/DDD system, class J07B

Ask your doctor or pharmacist for advice.